Göksu Haydar, Topal Meryem, Keskin Ali, Gültekin Mehmet S, Çelik Murat, Gülçin İlhami, Tanc Muhammet, Supuran Claudiu T
Kaynasli Vocational College, Düzce University, Düzce, Turkey.
Faculty of Science, Department of Chemistry, Atatürk University, Erzurum, Turkey.
Arch Pharm (Weinheim). 2016 Jun;349(6):466-74. doi: 10.1002/ardp.201600047. Epub 2016 May 13.
N-substituted maleimides were synthesized from maleic anhydride and primary amines. 1,4-Dibromo-dibenzo[e,h]bicyclo-[2,2,2]octane-2,3-dicarboximide derivatives (4a-f) were prepared by the [4+2] cycloaddition reaction of dibromoanthracenes with the N-substituted maleimide derivatives. The carbonic anhydrase (CA, EC 4.2.1.1) inhibitory effects of the new derivatives were assayed against the human (h) isozymes hCA I, II, IX, and XII. All tested bicyclo dicarboximide derivatives exhibited excellent inhibitory effects in the nanomolar range, with Ki values in the range of 117.73-232.87 nM against hCA I and of 69.74-111.51 nM against hCA II, whereas they were low micromolar inhibitors against hCA IX and XII.
N-取代马来酰亚胺由马来酸酐和伯胺合成。1,4-二溴-二苯并[e,h]双环-[2,2,2]辛烷-2,3-二甲酰亚胺衍生物(4a - f)通过二溴蒽与N-取代马来酰亚胺衍生物的[4+2]环加成反应制备。测定了新衍生物对人(h)同工酶hCA I、II、IX和XII的碳酸酐酶(CA, EC 4.2.1.1)抑制作用。所有测试的双环二甲酰亚胺衍生物在纳摩尔范围内均表现出优异的抑制作用,对hCA I的Ki值在117.73 - 232.87 nM范围内,对hCA II的Ki值在69.74 - 111.51 nM范围内,而它们对hCA IX和XII是低微摩尔抑制剂。